Kuijpers P M, Honig A, Griez E J, Braat S H, Wellens H J
Afd. Psychiatrie, Academisch Ziekenhuis, Maastricht.
Ned Tijdschr Geneeskd. 2000 Apr 15;144(16):732-6.
The prevalence of panic disorder in patients who present with chest pain or palpitations to a First Heart Aid setting varies in the literature between 0%-59%. In a high percentage of cases, panic disorder is not recognized by the cardiologist in patients who present initially with chest pain or palpitations. Patients with panic disorder have a large and ongoing medical consumption. A selective serotonin reuptake inhibitor and/or cognitive therapy appear to be good treatment of panic disorder in patients who present initially with chest pain or palpitations. A CO2 challenge test elicits the symptoms in patients with panic disorder with high sensitivity and specificity but this test has not been validated in patients who present initially with chest pain or palpitations and in whom the diagnosis 'panic disorder' is not yet established.
在因胸痛或心悸前往急救场所就诊的患者中，惊恐障碍的患病率在文献中的报道为0%至59%不等。在很大比例的病例中，最初因胸痛或心悸就诊的患者，其惊恐障碍未被心脏病专家识别。患有惊恐障碍的患者有大量且持续的医疗消费。选择性5-羟色胺再摄取抑制剂和/或认知疗法似乎是最初因胸痛或心悸就诊患者惊恐障碍的有效治疗方法。二氧化碳激发试验能以高敏感性和特异性诱发惊恐障碍患者的症状，但该试验尚未在最初因胸痛或心悸就诊且“惊恐障碍”诊断尚未确立的患者中得到验证。
